(Q42678199)

English

Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study

scientific article published on January 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jing-Jane Tsai

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Der-Jen Yen

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mo-Song Hsih

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Shung-Sheng Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Reinhard Hiersemenzel

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pascal Edrich

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Chi-Wan Lai

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

72-81

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Revisiting the concept of identifiable neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Rapid onset of action of levetiracetam in refractory epilepsy patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Inheritance and drug response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Pharmacogenetics and antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00372.X

21 January 2018

Identifiers

10.1111/J.1528-1167.2006.00372.X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42678199&oldid=2200399392"